Adrenocortical carcinoma (ACC) originates from the adrenal cortex and is typically defined
by positive immunostaining for steroidogenic factor 1 (SF1), melanA (Mart1) markers but …

Adrenocortical cancer (ACC) is a rare and often aggressive malignancy that requires
multidisciplinary expertise for optimal management. It can present with symptoms of rapidly …

Adrenocortical carcinoma is a rare heterogeneous neoplasm with an incompletely
understood pathogenesis and a poor prognosis. Previous studies have identified …

Adrenocortical carcinoma (ACC) is an orphan malignancy that has attracted increasing
attention during the last decade. Here we provide an update on advances in the field since …

Context: Adrenocortical carcinoma (ACC) is a rare and heterogeneous malignancy with
incompletely understood pathogenesis and poor prognosis. Patients present with hormone …

Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis, the five-years
overall survival being below 40%. However, there is great variability of outcomes and we …

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Due to its rarity,
heterogeneity, and a lack of a comprehensive understanding of the pathogenesis, little …

Objective Adrenocortical carcinoma (ACC) is a rare malignancy with a poor prognosis.
Herein, we describe the clinical features and outcomes for a large series of ACC patients …

Background Adrenocortical carcinoma is a rare cancer, with an incidence in the literature of
0.5 to 2 cases per million population per year. Adult adrenocortical carcinoma has a poor …

Adrenocortical carcinomas (ACC) are uncommon tumors of the adrenal cortex that are
known to follow an aggressive clinical course. The distinction of these tumors from other …